Pharmabiz24m
AstraZeneca reveals its ambition to deliver $80 billion total revenue by 2030
AstraZeneca reveals its ambition to deliver $80 billion total revenue by 2030: Cambridge, UK Wednesday, May 22, 2024, 09:00 Hrs [IST] AstraZeneca has revealed its bold ambition to ...
Pharmabiz1h
Karnataka Ayush dept approves Natureorama’s Sinkcan, a plant based concoction supportive therapy for cancer
Karnataka Ayush dept approves Natureorama’s Sinkcan, a plant based concoction supportive therapy for cancer: Nandita Vijayasimha, Bengaluru Wednesday, May 22, 2024, 08:00 Hrs [I ...
Pharmabiz1h
Despite repeated requests, majority of states did not submit spurious drugs alert data in April
Despite repeated requests, majority of states did not submit spurious drugs alert data in April: Gireesh Babu, New Delhi Wednesday, May 22, 2024, 08:00 Hrs [IST] Despite repeated ...
Pharmabiz1h
NABH asks healthcare organizations to strengthen their fire safety protocols
NABH asks healthcare organizations to strengthen their fire safety protocols: Shardul Nautiyal, Mumbai Wednesday, May 22, ...
Pharmabiz1h
ICMR to host workshop on biostatistics to enhance health research capabilities
ICMR to host workshop on biostatistics to enhance health research capabilities: Shardul Nautiyal, Mumbai Wednesday, May 22, 2024, 08:00 Hrs [IST] The Indian Council of Medical Res ...
Pharmabiz1h
Pharmaceuticals exports report 7.36 per cent growth in April
Exports of drugs and pharmaceuticals from the country registered a 7.36 per cent growth in the first month of the current fiscal year, while imports reported a significant jump of over 18 per cent ...
Pharmabiz15h
Ensysce Biosciences renews collaboration with Quotient Sciences to advance the clinical development of innovative overdose protection platform
Ensysce Biosciences renews collaboration with Quotient Sciences to advance the clinical development of innovative overdose protection platform: San Diego, California Tuesday, May ...
Pharmabiz19h
Biocon Biologics obtains US FDA nod for biosimilar aflibercept to treat different types of ophthalmology conditions
Biocon Biologics obtains US FDA nod for biosimilar aflibercept to treat different types of ophthalmology conditions: Our Bureau, Bengaluru Tuesday, May 21, 2024, 14:10 Hrs [IST] B ...
Pharmabiz17h
Pristyn Care and Mohak Bariatrics performs live bariatric surgery using Apple Vision Pro
Pristyn Care, in collaboration with Mohak Bariatrics and Robotics, has performed the world's first live bariatric surgery utilizing the Apple Vision Pro. This procedure, which included a sleeve ...
Pharmabiz18h
MediciNova to receive US patent covering MN-166 for prevention of metastasis of eye cancer
MediciNova to receive US patent covering MN-166 for prevention of metastasis of eye cancer: La Jolla, California Tuesday, May 21, 2024, 15:00 Hrs [IST] MediciNova, Inc., a biophar ...
Pharmabiz16h
Coya Therapeutics announces $5 million strategic investment by the Alzheimer’s Drug Discovery Foundation
Coya Therapeutics announces $5 million strategic investment by the Alzheimer’s Drug Discovery Foundation: Houston Tuesday, May 21, 2024, 17:00 Hrs [IST] Coya Therapeutics, Inc., ...
Pharmabiz17h
Amgen, AstraZeneca announce positive results from phase 2a COURSE trial of Tezspire in people with moderate to very severe COPD
Thousand Oaks, California Tuesday, May 21, 2024, 16:00 Hrs [IST] ...